🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a single arm, open label study of up to 24 high risk prostate cance...
Status
Completed
Location
Weill Cornell Medical College
Start Date
2012-01
Trial ID
NCT01572701
Treatments Being Tested
99mTc-MIP-1404 is a radioactive diagnostic imaging agent indicated for imag...
Status
Completed
Location
City of Hope Cancer Center
Start Date
2015-12
Trial ID
NCT02615067
Treatments Being Tested
This was a multicenter, multi-reader, open-label, Phase 2 study assessing t...
Status
Completed
Location
City of Hope National Cancer Center
Start Date
2012-08
Trial ID
NCT01667536
Treatments Being Tested
This is a single-blind, randomized, cross-over design. Patients with metast...
Status
Completed
Location
New York Presbyterian Hospital - Weill Medical College of Cornell University
Start Date
2010-12
Trial ID
NCT01261754
Treatments Being Tested
This trial is a single-blind, cross-over design. Up to three patients with ...
Status
Completed
Location
New York Presbyterian Hospital, Weill Cornell Medical College
Start Date
2012-07
Trial ID
NCT01654874
Treatments Being Tested
This is a single arm, open label study of up to 24 prostate cancer patients...
Status
Completed
Location
The University of Texas Health Science Center - Houston
Start Date
2012-04
Trial ID
NCT01615406
Treatments Being Tested
Prostate cancer (PCa) is currently the most common cancer in men in Finland...
Status
Recruiting
Location
University Hospital of Turku, Hospital Distric of Southwest Finland
Start Date
2022-06-01
Trial ID
NCT06219746
Treatments Being Tested